Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies

Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies

BACKGROUND: There is limited clinical trial and/or real-world evidence comparing differences among currently approved fixed-dose combination (FDC) long-Acting muscarinic antagonist (LAMA)/long-Acting beta2-Agonist (LABA) treatments. OBJECTIVE: To compare chronic obstructive pulmonary disease (COPD)-...

Full description

Bibliographic Details
Main Authors: Bengtson, L.G.S (Author), Chastek, B. (Author), Palli, S.R (Author), Xie, B. (Author)
Format: Article
Language:English
Published: Academy of Managed Care Pharmacy (AMCP) 2021
Subjects:
aclidinium bromide
aclidinium bromide plus formoterol fumarate
Administration, Inhalation
Adrenergic beta-2 Receptor Agonists
age
aged
Aged
antibiotic agent
Article
benzoxazine derivative
Benzoxazines
benzyl alcohol derivative
Benzyl Alcohols
beta 2 adrenergic receptor stimulating agent
bibliographic database
bronchodilating agent
Bronchodilator Agents
chlorobenzene
Chlorobenzenes
chronic obstructive lung disease
clinical outcome
cohort analysis
comparative study
consultation
corticosteroid
data analysis software
delayed release formulation
Delayed-Action Preparations
disease exacerbation
drug combination
Drug Combinations
economics
emergency health service
emergency ward
female
Female
follow up
formoterol fumarate plus glycopyrronium bromide
glycopyrronium bromide plus indacaterol
health care cost
health care utilization
health insurance
hospital patient
human
Humans
inhalational drug administration
length of stay
long acting drug
maintenance therapy
major clinical study
male
Male
medicare
middle aged
Middle Aged
monotherapy
Muscarinic Antagonists
muscarinic receptor blocking agent
observational study
olodaterol plus tiotropium bromide
outpatient care
oxygen
oxygen therapy
Patient Acceptance of Health Care
patient attitude
pharmacy (shop)
practice guideline
propensity score
Pulmonary Disease, Chronic Obstructive
quinuclidine derivative
Quinuclidines
Retrospective Studies
retrospective study
sex factor
statistical analysis
tiotropium bromide
Tiotropium Bromide
tiotropium-olodaterol
umeclidinium
umeclidinium plus vilanterol
United States
vilanterol
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items